Wilson I R, Hurrell M A, Pattinson N R, Chapman B A
Department of Gastroenterology, Christchurch Hospital, New Zealand.
J Gastroenterol Hepatol. 1994 Sep-Oct;9(5):447-51. doi: 10.1111/j.1440-1746.1994.tb01272.x.
Female non-insulin-dependent diabetics have a high prevalence of gallstones. Treatment of hyperlipidaemia in these patients may modify the risk. Seventeen female non-insulin-dependent diabetics (age 35-65) were treated with simvastatin (n = 10) or bezafibrate (n = 7) and had the cholesterol saturation index (CSI) of bile and gall-bladder emptying measured before and after 3 months therapy. In both groups, there was a significant reduction in serum cholesterol following treatment. The mean pretreatment cholesterol saturation indices of bile did not differ between the two groups but, after 3 months therapy, there was a highly significant difference in CSI between the bezafibrate group (2.0 +/- 0.33) and the simvastatin group (1.1 +/- 0.14) P < 0.002. Whereas the increase in the CSI (42%) observed with bezafibrate therapy was significant, the decrease in the simvastatin group (14%) was only significant in those whose pretreatment cholesterol saturation indices were elevated. Despite the differences in CSI observed between the two treatment groups, no changes in gall-bladder emptying were detected.
女性非胰岛素依赖型糖尿病患者胆结石的患病率较高。对这些患者进行高脂血症治疗可能会改变风险。17名年龄在35至65岁之间的女性非胰岛素依赖型糖尿病患者接受了辛伐他汀(n = 10)或苯扎贝特(n = 7)治疗,并在治疗3个月前后测量了胆汁的胆固醇饱和指数(CSI)和胆囊排空情况。两组治疗后血清胆固醇均显著降低。两组治疗前胆汁的平均胆固醇饱和指数无差异,但治疗3个月后,苯扎贝特组(2.0 +/- 0.33)和辛伐他汀组(1.1 +/- 0.14)的CSI存在高度显著差异,P < 0.002。苯扎贝特治疗使CSI升高(42%)具有显著性,而辛伐他汀组降低(14%)仅在治疗前胆固醇饱和指数升高的患者中具有显著性。尽管两个治疗组的CSI存在差异,但未检测到胆囊排空有变化。